Evidence map›Paper›PMID 34010338›Full record

ArticlePloS one2021

Public support for harm reduction: A population survey of Canadian adults.

T Cameron Wild, Jakob Koziel, Jalene Anderson-Baron, Mark Asbridge, Lynne Belle-Isle, Colleen Dell, Richard Elliott, Andrew Hathaway, Donald MacPherson, Keely McBride and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Responding to an evolving crisis: Meeting the needs of a growing population who smoke their unregulated substances.Canadian journal of public health = Revue canadienne de sante publique · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 1 country.

T Cameron WildSchool of Public Health, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0002-9947-7428
Jakob KozielSchool of Public Health, University of Alberta, Edmonton, Alberta, Canada.
Jalene Anderson-BaronSchool of Public Health, University of Alberta, Edmonton, Alberta, Canada.
Mark AsbridgeDepartment of Community Health and Epidemiology, Department of Emergency Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Lynne Belle-IsleCanadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.
Colleen DellDepartment of Sociology, School of Public Health, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Richard ElliottCanadian HIV/AIDS Legal Network, Toronto, Ontario, Canada.
Andrew HathawayDepartment of Sociology and Anthropology, University of Guelph, Guelph, Ontario, Canada.
Donald MacPhersonCanadian Drug Policy Coalition, Vancouver, British Columbia, Canada.
Keely McBrideAlberta Health, Edmonton, Alberta, Canada.
Bernie PaulyCanadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.
Carol StrikeDalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Adam GalovanDepartment of Human Ecology, University of Alberta, Edmonton, Alberta, Canada.
Elaine HyshkaSchool of Public Health, University of Alberta, Edmonton, Alberta, Canada.
University of Alberta · CAUniversity of Victoria · CAAlberta Health · CACanadian Centre for Policy Alternatives · CADalhousie University · CAHIV Legal Network · CAUniversity of Guelph · CAUniversity of Saskatchewan · CAUniversity of Toronto · CA

Funding

CIHR MOP 137073
6 · The paper itself

Abstract

We described public views toward harm reduction among Canadian adults and tested a social exposure model predicting support for these contentious services, drawing on theories in the morality policy, intergroup relations, addiction, and media communication literatures. A quota sample of 4645 adults (18+ years), randomly drawn from an online research panel and stratified to match age and sex distributions of adults within and across Canadian provinces, was recruited in June 2018. Participants completed survey items assessing support for harm reduction for people who use drugs (PWUD) and for seven harm reduction interventions. Additional items assessed exposure to media coverage on harm reduction, and scales assessing stigma toward PWUD (α = .72), personal familiarity with PWUD (α = .84), and disease model beliefs about addiction (α = .79). Most (64%) Canadians supported harm reduction (provincial estimates = 60% - 73%). Five of seven interventions received majority support, including: outreach (79%), naloxone (72%), drug checking (70%), needle distribution (60%) and supervised drug consumption (55%). Low-threshold opioid agonist treatment and safe inhalation interventions received less support (49% and 44%). Our social exposure model, adjusted for respondent sex, household income, political views, and education, exhibited good fit and accounted for 17% of variance in public support for harm reduction. Personal familiarity with PWUD and disease model beliefs about addiction were directly associated with support (βs = .07 and -0.10, respectively), and indirectly influenced public support via stigmatized attitudes toward PWUD (βs = 0.01 and -0.01, respectively). Strategies to increase support for harm reduction could problematize certain disease model beliefs (e.g., "There are only two possibilities for an alcoholic or drug addict-permanent abstinence or death") and creating opportunities to reduce social distance between PWUD, the public, and policy makers.

Indexed as

AttitudeHarm ReductionPublic OpinionSocial StigmaAdolescentAdultAgedAged, 80 and overAwarenessCanadaCommunity-Institutional RelationsFemaleHumansMaleMiddle AgedNeedle-Exchange Programs

Identifiers

PMID34010338
PMCPMC8133460
OpenAlexW3161456113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.